Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Longboard Pharmaceuticals ( (LBPH) ) has issued an update.
In a significant financial move, the acquisition of a company was completed through a cash tender offer at $60 per share, with over 88.6% of shares tendered. The subsequent merger led to the company’s shares being delisted from Nasdaq and deregistered with the SEC, marking a transition as it became an indirect wholly-owned subsidiary of the parent company. Stock options and RSUs were converted into cash rights, reflecting a streamlined corporate restructuring.
Learn more about LBPH stock on TipRanks’ Stock Analysis page.